Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid

Journal of Virological Methods

Volumn 171, Issue 1, 2011, Pages 169-175

  Gutierrez, Julio A ^a,b   Klepper, Arielle L ^a   Garber, John ^a   Walewski, Jose L ^a   Bateman, Kristin ^a   Khaitova, Viktoriya ^a   Syder, Andrew ^c   Tscherne, Donna M ^c   Gauthier, Annick ^c   Jefferson, Douglas ^d   Rice, Charles M ^c   Schiano, Thomas D ^a   Branch, Andrea D ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SAN DIEGO   (United States)

^c ROCKEFELLER UNIVERSITY   (United States)

^d TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anti HCV antibodies; Ascitic fluid; Core; Hepatitis C virus; Immunofluorescence; NS4B; NS5A

Indexed keywords

CELL EXTRACT; CORE PROTEIN; HEPATITIS C ANTIBODY; IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; NONSTRUCTURAL PROTEIN 4B; NONSTRUCTURAL PROTEIN 5A; POLYCLONAL ANTIBODY; PROTEIN A; SYNTHETIC PEPTIDE;

ADULT; AGED; ANTIBODY TITER; ANTIGEN ANTIBODY REACTION; ARTICLE; ASCITES FLUID; CHROMATOGRAPHY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LIVER CIRRHOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PURIFICATION; REPLICON;

AGED; ASCITIC FLUID; CROSS REACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; VIRAL CORE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS;

EID: 78650553173     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2010.10.020     Document Type: Article

References (31)

1. Ballardini G., De Raffele E., Groff P., Bioulac-Sage P., Grassi A., Ghetti S., Susca M., Strazzabosco M., Bellusci R., Iemmolo R.M., Grazi G., Zauli D., Cavallari A., Bianchi F.B. Timing of reinfection and mechanisms of hepatocellular damage in transplanted hepatitis C virus-reinfected liver. Liver Transpl. 2002, 8:10-20.
2. Blight K.J., McKeating J.A., Rice C.M. Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication. J. Virol. 2002, 76:13001-13014.
3. Brillet R., Penin F., Hezode C., Chouteau P., Dhumeaux D., Pawlotsky J.M. The nonstructural 5A protein of hepatitis C virus genotype 1b does not contain an interferon sensitivity-determining region. J. Infect. Dis. 2007, 195:432-441.
4. Desombere I., Van Vlierberghe H., Weiland O., Hultgren C., Sallberg M., Quiroga J., Carreno V., Leroux-Roels G. Serum levels of anti-NS4a and anti-NS5a predict treatment response of patients with chronic hepatitis C. J. Med. Virol. 2007, 79:701-713.
5. Egger D., Wolk B., Gosert R., Bianchi L., Blum H.E., Moradpour D., Bienz K. Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J. Virol. 2002, 76:5974-5984.
6. Einav S., Sklan E.H., Moon H.M., Gehrig E., Liu P., Hao Y., Lowe A.W., Glenn J.S. The nucleotide binding motif of hepatitis C virus NS4B can mediate cellular transformation and tumor formation without Ha-ras co-transfection. Hepatology 2008, 47:827-835.
7. Eng F.J., Walewski J.L., Klepper A.L., Fishman S.L., Desai S.M., McMullan L.K., Evans M.J., Rice C.M., Branch A.D. Internal initiation stimulates production of p8 minicore, a member of a newly discovered family of hepatitis C virus core protein isoforms. J. Virol. 2009, 83:3104-3114.
8. Epstein M. Treatment of refractory ascites. N. Engl. J. Med. 1989, 321:1675-1677.
9. Fenwick F., Bassendine M.F., Agarwal K., Bevitt D., Pumeechockchai W., Burt A.D., Toms G.L. Immunohistochemical assessment of hepatitis C virus antigen in cholestatic hepatitis after liver transplantation. J. Clin. Pathol. 2006, 59:174-178.
10. Feray C., Gigou M., Samuel D., Ducot B., Maisonneuve P., Reynes M., Bismuth A., Bismuth H. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann. Intern. Med. 1998, 128:810-816.
11. Fishman S.L., Branch A.D. The quasispecies nature and biological implications of the hepatitis C virus. Infect. Genet. Evol. 2009.
12. Flint M., Maidens C., Loomis-Price L.D., Shotton C., Dubuisson J., Monk P., Higginbottom A., Levy S., McKeating J.A. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 1999, 73:6235-6244.
13. Gabrielli A., Zhang Z.X., Cherubini G., Candela M., Savoldi S., Manzin A., Clementi M., Amoroso A., Sallberg M. Differential humoral immune response against hepatitis C virus antigenic synthetic peptides in infected patients with and without mixed cryoglobulinaemia. Clin. Exp. Immunol. 1996, 105:59-64.
14. Garcia-Tsao G. Portal hypertension. Curr. Opin. Gastroenterol. 2002, 18:351-359.
15. Grassi A., Quarneti C., Ravaioli M., Bianchini F., Susca M., D'Errico A., Piscaglia F., Tame M.R., Andreone P., Grazi G., Galli S., Zauli D., Pinna A.D., Bianchi F.B., Ballardini G. Detection of HCV antigens in liver graft: relevance to the management of recurrent post-liver transplant hepatitis C. Liver Transpl. 2006, 12:1673-1681.
16. Knodell R.G., Conrad M.E., Ginsberg A.L., Bell C.J. Efficacy of prophylactic gamma-globulin in preventing non-A, non-B post-transfusion hepatitis. Lancet 1976, 1:557-561.
17. Konan K.V., Giddings T.H., Ikeda M., Li K., Lemon S.M., Kirkegaard K. Nonstructural protein precursor NS4A/B from hepatitis C virus alters function and ultrastructure of host secretory apparatus. J. Virol. 2003, 77:7843-7855.
18. Lindenbach B.D., Evans M.J., Syder A.J., Wolk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 2005, 309:623-626.
19. Lundin M., Monne M., Widell A., Von Heijne G., Persson M.A. Topology of the membrane-associated hepatitis C virus protein NS4B. J. Virol. 2003, 77:5428-5438.
20. Piazza M., Sagliocca L., Tosone G., Guadagnino V., Stazi M.A., Orlando R., Borgia G., Rosa D., Abrignani S., Palumbo F., Manzin A., Clementi M. Sexual transmission of hepatitis C virus and prevention with intramuscular immunoglobulin. AIDS Patient Care and STDS 1998, 12:611-618.
21. Randall G., Panis M., Cooper J.D., Tellinghuisen T.L., Sukhodolets K.E., Pfeffer S., Landthaler M., Landgraf P., Kan S., Lindenbach B.D., Chien M., Weir D.B., Russo J.J., Ju J., Brownstein M.J., Sheridan R., Sander C., Zavolan M., Tuschl T., Rice C.M. Cellular cofactors affecting hepatitis C virus infection and replication. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:12884-12889.
22. Sanchez-Quijano A., Pineda J.A., Lissen E., Leal M., Diaz-Torres M.A., Garcia De Pesquera F., Rivera F., Castro R., Munoz J. Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet 1988, 1:1245-1249.
23. Seeff L.B. Natural history of chronic hepatitis C. Hepatology 2002, 36:S35-46.
24. Takao Y., Yamada A., Yutani S., Ono T., Nagao Y., Ando E., Ide T., Itoh K., Sata M. Serum levels of IgG to the peptide of HCV1b core at positions 35-44 correlated with persistent infection, while levels of IgG to the peptide of NS5A at positions 2132-2140 correlated with better prognosis in HCV-infected patients. Med. Microbiol. Immunol. 2007, 196:157-164.
25. Tasaka M., Sakamoto N., Itakura Y., Nakagawa M., Itsui Y., Sekine-Osajima Y., Nishimura-Sakurai Y., Chen C.H., Yoneyama M., Fujita T., Wakita T., Maekawa S., Enomoto N., Watanabe M. Hepatitis C virus non-structural proteins responsible for suppression of the RIG-I/Cardif-induced interferon response. J. Gen. Virol. 2007, 88:3323-3333.
26. Tellinghuisen T.L., Marcotrigiano J., Gorbalenya A.E., Rice C.M. The NS5A protein of hepatitis C virus is a zinc metalloprotein. J. Biol. Chem. 2004, 279:48576-48587.
27. Tscherne D.M., Evans M.J., von Hahn T., Jones C.T., Stamataki Z., McKeating J.A., Lindenbach B.D., Rice C.M. Superinfection exclusion in cells infected with hepatitis C virus. J. Virol. 2007, 81:3693-3703.
28. Vanwolleghem T., Bukh J., Meuleman P., Desombere I., Meunier J.C., Alter H., Purcell R.H., Leroux-Roels G. Polyclonal immunoglobulins from a chronic hepatitis C virus patient protect human liver-chimeric mice from infection with a homologous hepatitis C virus strain. Hepatology 2008, 47:1846-1855.
29. Walewski J.L., Keller T.R., Stump D.D., Gutierrez J.A., Branch-Elliman W., Rodriguez A., Benson G., Branch A.D. A target domain in the newly-discovered HCV alternate reading frame protein identified with a novel sequence analysis package. Hepatology 2001, 34:1091.
30. Yu G.Y., Lee K.J., Gao L., Lai M.M. Palmitoylation and polymerization of hepatitis C virus NS4B protein. J. Virol. 2006, 80:6013-6023.
31. Zhang Z.X., Chen M., Sonnerborg A., Weiland O., Sallberg M. Distinguishing acute from symptomatic chronic hepatitis C virus (HCV) infection by site-directed serology of the HCV structural proteins. J. Infect. Dis. 1995, 171:1356-1359.